Christina Baik, MD MPH

No bio available.

Financial relationships

  • Attribution:
    Other
    Type of financial relationship:
    Other
    Ineligible company:
    BlackDiamond
    Topic:
    Clinical trial funding
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Other
    Type of financial relationship:
    Other
    Ineligible company:
    Abbvie
    Topic:
    Clinical trial funding
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Other
    Type of financial relationship:
    Other
    Ineligible company:
    BMS
    Topic:
    Clinical trial funding
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Other
    Type of financial relationship:
    Other
    Ineligible company:
    TurningPoint
    Topic:
    Clinical trial funding
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Other
    Type of financial relationship:
    Other
    Ineligible company:
    AstraZeneca
    Topic:
    Clinical trial funding
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Other
    Type of financial relationship:
    Other
    Ineligible company:
    Lilly
    Topic:
    Clinical trial funding
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Other
    Type of financial relationship:
    Other
    Ineligible company:
    Pfizer
    Topic:
    Clinical trial funding
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Other
    Type of financial relationship:
    Other
    Ineligible company:
    Jansen
    Topic:
    Clinical trial funding
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Other
    Type of financial relationship:
    Other
    Ineligible company:
    Boehringer
    Topic:
    Clinical trial funding
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Other
    Type of financial relationship:
    Other
    Ineligible company:
    Ellipses
    Topic:
    Clinical trial funding
    Date added:
    07/01/2024
    Date updated:
    07/01/2024

Pages

Return to 2024 Seattle Lung Cancer Conference